Browsing Tag
Polyrizon Ltd.
3 posts
How intranasal delivery could reshape Clearmind Medicine Inc.’s MEAI development strategy in addiction
Find out how Clearmind Medicine Inc.’s intranasal MEAI strategy could reshape addiction drug development risk and execution.
Will Polyrizon’s $5.8m move into private aviation reshape its biotech-focused capital strategy? (NASDAQ: PLRZ)
Polyrizon plans to buy 51% of Arrow Aviation in a $5.8M deal. Find out how this biotech-to-aviation pivot could reshape its capital strategy.
Polyrizon achieves major production milestone for PL-14 nasal spray as 2026 clinical trial preparation accelerates
Polyrizon has successfully scaled production of its PL-14 intranasal hydrogel to clinical-trial grade, clearing a critical hurdle ahead of its planned 2026 human study.